Notification in terms of Section 122(3) of The Companies Act and Section 3.83(b) of The JSE Listings Requirements ASPEN PHARMACARE HOLDINGS LIMITED (Incorporated in the Republic of South Africa) Registration number 1985/0002935/06 Share code: APN ISIN: ZAE000066692 ("Aspen" or "the Company") NOTIFICATION IN TERMS OF SECTION 122(3) OF THE COMPANIES ACT AND SECTION 3.83(b) OF THE JSE LISTINGS REQUIREMENTS In accordance with section 122(3)(b) of the Companies Act, No. 71 of 2008 (“the Act”) and section 3.83(b) of the JSE Listings Requirements, holders of ordinary shares in the Company are advised that Harding Loevner LP have formally notified the Company that they have acquired a beneficial interest in the securities of the Company now amounting to 5.06% of the ordinary share capital of the Company, effective 29 March 2018. Aspen will file the required notice with the Takeover Regulation Panel as required in terms of section 122(3)(a) of the Act. Durban 5 April 2018 Sponsor Investec Bank Limited Date: 05/04/2018 12:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.
Email this JSE Sens Item to a Friend.